BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/12/2021 5:45:28 AM | Browse: 353 | Download: 658
 |
Received |
|
2021-01-21 10:46 |
|
Peer-Review Started |
|
2021-01-21 10:46 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-16 06:40 |
|
Revised |
|
2021-04-05 03:44 |
|
Second Decision |
|
2021-06-04 08:32 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-06-04 09:06 |
|
Articles in Press |
|
2021-06-04 09:06 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-06-15 00:16 |
|
Typeset the Manuscript |
|
2021-07-06 00:52 |
|
Publish the Manuscript Online |
|
2021-07-12 05:45 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Basic Study |
| Article Title |
Possible drug for type 2 diabetes-decarboxylated osteocalcin triggers glucose uptake in MG63 cells
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shi Jin, Xiao-Cen Chang, Jing Wen, Jing Yang, Na Ao, Ke-Ying Zhang, Lin-Na Suo and Jian Du |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Provincial Science and Technology Department Natural Fund Guidance Project |
2019-ZD-0774 |
| National Natural Science Foundation of China |
81470998 |
| Liaoning Ministry of Education |
LQNK201715 |
| Liaoning Provincial Doctor Start up Fund |
20180540008 |
|
| Corresponding Author |
Jian Du, PhD, Professor, Department of Endocrinology, The Fourth Affiliated Hospital of China Medical University, No. 4 Chongshan Road, Huanggu District, Shenyang 110032, Liaoning Province, China. dujian_1962@163.com |
| Key Words |
Decarboxylated osteocalcin; Osteoblast; Glucose uptake; Glucose transporter 1; Type 2 diabetes |
| Core Tip |
Uncarboxylated osteocalcin (GluOC) has been reported to improve glucose metabolism and prevent type 2 diabetes. GluOC can increase the glucose uptake in a variety of cells. In this study, MG63 cells were treated with different concentrations of decarboxylated osteocalcin (dcOC) for 1 h and 72 h to observe the changes in glucose uptake, proliferation and alkaline phosphatase (ALP) activity, as well as possible signaling pathway. Short- or long-term intervention with dcOC in vitro can increase glucose uptake and promote the proliferation and ALP activity of MG63 cells. This effect may occur through the PI3K/Akt, hypoxia-inducible factor 1 alpha and glucose transporter 1 signaling factors. |
| Publish Date |
2021-07-12 05:45 |
| Citation |
Jin S, Chang XC, Wen J, Yang J, Ao N, Zhang KY, Suo LN, Du J. Possible drug for type 2 diabetes-decarboxylated osteocalcin triggers glucose uptake in MG63 cells. World J Diabetes 2021; 12(7): 1102-1115 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i7/1102.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i7.1102 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
